Nanobiotix (NBTX) Institutional Ownership $3.70 -0.13 (-3.39%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Nanobiotix (NASDAQ:NBTX)CurrentInstitutional OwnershipPercentage38.81%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$6.79MNumber ofInstitutional Sellers(last 12 months)0 Get NBTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Nanobiotix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NBTX Institutional Buying and Selling by Quarter Ad Porter & CompanyWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. Nanobiotix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/26/2024 Baillie Gifford & Co.2,869,030$20.89M0.0%+48.2%6.087% 11/13/2023 Baillie Gifford & Co.1,936,195$16.94M0.0%+38.3%5.350% 11/9/2023 Johnson & Johnson959,637$8.40M3.1%N/A2.652% 8/17/2021 Woodline Partners LP59,994$827K0.0%-7.0%0.174% 5/18/2021 Millennium Management LLC22,082$332K0.0%-53.3%0.066% 5/17/2021 Perceptive Advisors LLC1,059,800$15.94M0.2%-3.7%3.043% 5/17/2021 Woodline Partners LP64,514$970K0.0%-7.8%0.194% 5/12/2021 UBS Group AG70,182$1.06M0.0%+20,183.8%0.211% 2/16/2021 Orbimed Advisors LLC500,000$8.25M0.1%N/A1.500% 2/11/2021 Artal Group S.A.1,000,000$16.50M0.4%N/A2.999% 2/11/2021 Monashee Investment Management LLC15,000$248K0.0%N/A0.045% 2/11/2021 Tybourne Capital Management HK Ltd.750,000$12.38M0.3%N/A2.250% 2/10/2021 Baillie Gifford & Co.1,400,000$23.10M0.0%N/A4.199% (Data available from 1/1/2016 forward) NBTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NBTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Nanobiotix shares: Baillie Gifford & Co. ($20.89M), Johnson & Johnson ($8.40M).Learn more on NBTX's institutional investors. What percentage of Nanobiotix stock is owned by institutional investors? 38.81% of Nanobiotix stock is owned by institutional investors. Learn more on NBTX's institutional investor holdings. Which institutional investors have been buying Nanobiotix stock? The following institutional investors have purchased Nanobiotix stock in the last 24 months: Baillie Gifford & Co. ($1.47M), and Johnson & Johnson ($959.64K). How much institutional buying is happening at Nanobiotix? Institutional investors have bought a total of 2,428,667 shares in the last 24 months. This purchase volume represents approximately $19.88M in transactions. Related Companies Cullinan Therapeutics Institutional Ownership Entrada Therapeutics Institutional Ownership Tectonic Therapeutic Institutional Ownership Arbutus Biopharma Institutional Ownership AnaptysBio Institutional Ownership Phathom Pharmaceuticals Institutional Ownership ORIC Pharmaceuticals Institutional Ownership Exscientia Institutional Ownership CorMedix Institutional Ownership Stoke Therapeutics Institutional Ownership This page (NASDAQ:NBTX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBTX Stock Alerts